HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

Go back to HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 76.11 --0 (-0%)
Previous Close $76.11    52 Week High $18.39 
Open $76.11    52 Week Low $6.96 
Day High $76.11    P/E N/A 
Day Low $76.11    EPS $-0.58 
Volume 1,181